Delivery Order SPE2DB22D3301-SPE2DB24FZ0EZ

Award Date 7/10/24
Potential Completion Date 7/11/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ETONOGESTREL-EE VAGINAL RINGS to the Defense Logistics Agency (DLA). The contract, valued at $1,313.82, is a firm fixed-price delivery order that runs through June 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. The IDC serves as the primary vehicle...
This federal contract award is for the delivery of Etonogestrel-EE vaginal rings to the Defense Logistics Agency (DLA). The $3,250.23 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 2, 2024 with a completion date of May 3, 2024. This award is under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC,...
This federal contract award is for the delivery of Etonogestrel-EE vaginal rings, with a ceiling value of $1,076.04. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 22, 2025. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,644.69, is for the delivery of Etonogestrel-EE Vaginal Rings, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 7, 2025. The contract was not designated with a set-aside requirement, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,673.52, is for the delivery of Etonogestrel-EE vaginal rings. It is a firm fixed-price delivery order contract that will run through March 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of ETONOGESTREL-EE VAGINAL RINGS to the Defense Logistics Agency (DLA). The $1,720.60 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 10, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Etonogestrel-EE vaginal rings. The contract has a firm fixed price of $3,709.62 and a performance period ending on April 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,699.36, is for the delivery of etonogestrel-EE vaginal rings. This is a firm fixed price delivery order contract with an ultimate completion date of April 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.05 firm-fixed-price delivery order is for Etonogestrel-EE Vaginal Rings, with a performance period extending through July 1, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Etonogestrel-EE vaginal rings to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a $1,344.56 Firm Fixed Price Delivery Order, with a completion date of June 9, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ0EZ
    Delivery Order

This federal contract award is for the provision of Etonogestrel-EE Vaginal Rings to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp's Corporate Office Division. The contract is a Delivery Order with a Firm Fixed Price of $3,053.99 and a completion date of July 11, 2024.

AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

The contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 10/9/24, 9:28 AM